Ligand Pharmaceuticals Inc - Sep 30, 2022 Form 3 Insider Report for OmniAb, Inc. (NONE)

Role
10%+ Owner
Signature
/s/ Charles S. Berkman, Senior Vice President, General Counsel and Secretary of Ligand Pharmaceuticals Incorporated
Stock symbol
NONE
Transactions as of
Sep 30, 2022
Transactions value $
$0
Form type
3
Date filed
9/30/2022, 07:59 PM
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NONE Common Stock 1K Sep 30, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.